After what phrase of clinical trial the drug can be registered?

Usually after Phase 3, but sometimes (rare disease/promising drug) also after Phase 2

Worth mentioning is that regulatory approval after phase 2 happens more frequently in the US rather than in the EU and this still does not preclude the developing company from conducting phase 3 studies.

Well you see if you dont follow ur parent's expectations or rule you're going to get a beat